Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace On-Demand Webinar Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace See how Phoenix NLME and RsNLME support scalable and manageable workflows as project demands evolve.Danielle Pillsbury2026年5月8日
What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD Blog What We Learned at Phoenix UGM at Certainty 2026 About the Future of PK/PD JTVCdGVhbV9qdW1wX2xpc3QlNUQ= 2026年5月8日 At Certainty 2026, the Phoenix User Group Meeting brought together scientists,…Certara2026年5月8日
Designing Drug Development Programs for Reimbursement Success Guide Designing Drug Development Programs for Reimbursement Success Download the guide to learn how model-informed drug development, QSP, and MBMA help align with…Certara2026年5月7日
Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint On-Demand Webinar Pharmacometrics Under Pressure: The Quantitative Clinical Pharmacology Sprint Explore how Phoenix NLME and RsNLME support early phase clinical pharmacology workflows where speed, clarity,…Certara2026年5月6日
GxP Compliance in the Cloud: What IT Teams Need to Rethink Blog GxP Compliance in the Cloud: What IT Teams Need to Rethink Learn how GxP validation works in modern SaaS and cloud environments, with best practices for…Certara2026年5月4日
Allometric Approach in pharmacokinetics when and how to use it Webinar Allometric Approach in pharmacokinetics when and how to use it Danielle Pillsbury2026年4月28日
From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development Blog From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…Certara2026年4月28日
ADC Dose Optimization: Applying Model-Informed Strategies in Development Blog ADC Dose Optimization: Applying Model-Informed Strategies in Development Explore ADC dose optimization using model-informed strategies to balance efficacy and safety across antibody drug…Certara2026年4月22日
Mean Residence Time (MRT): Understanding How Long Drug Molecules Stay in the Body BlogKnowledge Base Mean Residence Time (MRT): Understanding How Long Drug Molecules Stay in the Body JTVCdGVhbV9qdW1wX2xpc3QlNUQ= 2026年4月16日 When I first began learning about pharmacokinetics (PK), I was often…Certara2026年4月16日
When pharmacokinetics meets pharmacogenomics: Genetic Insights into Fluoxetine PK for Personalized Antidepressant Therapy Webinar When pharmacokinetics meets pharmacogenomics: Genetic Insights into Fluoxetine PK for Personalized Antidepressant Therapy Certara2026年4月10日